1. Home
  2. MLKN vs PCRX Comparison

MLKN vs PCRX Comparison

Compare MLKN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLKN
  • PCRX
  • Stock Information
  • Founded
  • MLKN 1905
  • PCRX 2006
  • Country
  • MLKN United States
  • PCRX United States
  • Employees
  • MLKN N/A
  • PCRX N/A
  • Industry
  • MLKN Office Equipment/Supplies/Services
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLKN Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • MLKN Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • MLKN 1.0B
  • PCRX 1.2B
  • IPO Year
  • MLKN N/A
  • PCRX 2011
  • Fundamental
  • Price
  • MLKN $16.78
  • PCRX $25.12
  • Analyst Decision
  • MLKN
  • PCRX Buy
  • Analyst Count
  • MLKN 0
  • PCRX 9
  • Target Price
  • MLKN N/A
  • PCRX $29.89
  • AVG Volume (30 Days)
  • MLKN 471.1K
  • PCRX 745.0K
  • Earning Date
  • MLKN 06-25-2025
  • PCRX 05-08-2025
  • Dividend Yield
  • MLKN 4.48%
  • PCRX N/A
  • EPS Growth
  • MLKN N/A
  • PCRX N/A
  • EPS
  • MLKN 0.43
  • PCRX N/A
  • Revenue
  • MLKN $3,597,000,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • MLKN $1.97
  • PCRX $9.48
  • Revenue Next Year
  • MLKN $3.05
  • PCRX $11.31
  • P/E Ratio
  • MLKN $39.33
  • PCRX N/A
  • Revenue Growth
  • MLKN N/A
  • PCRX 3.08
  • 52 Week Low
  • MLKN $15.25
  • PCRX $11.16
  • 52 Week High
  • MLKN $31.73
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • MLKN 48.68
  • PCRX 48.10
  • Support Level
  • MLKN $15.77
  • PCRX $25.08
  • Resistance Level
  • MLKN $16.78
  • PCRX $27.34
  • Average True Range (ATR)
  • MLKN 0.53
  • PCRX 1.16
  • MACD
  • MLKN 0.19
  • PCRX -0.18
  • Stochastic Oscillator
  • MLKN 88.33
  • PCRX 48.85

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: